Ownership history in PVG ASSET MANAGEMENT CORP · 6 quarters on record
This page tracks every 13F SEC filing in which PVG ASSET MANAGEMENT CORP reported a position in Anavex Life Sciences Corp. (avxl) (AVXL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 216,295 | +83,147 | +62.4% | 1.64% | $770K | $3.56 |
| 2025 Q3 | ADDED | 133,148 | +21,703 | +19.5% | 4.36% | $1.2M | $8.90 |
| 2025 Q2 | ADDED | 111,445 | +28,837 | +34.9% | 3.50% | $1.0M | $9.22 |
| 2025 Q1 | ADDED | 82,608 | +4,118 | +5.2% | 3.09% | $709K | $8.58 |
As of 2025 Q4 — sorted by position size